Your browser doesn't support javascript.
loading
pH-responsive glycodendrimer as a new active targeting agent for doxorubicin delivery.
Soltani, Ali; Faramarzi, Mehdi; Farjadian, Fatemeh; Parsa, Seyed Aboutaleb Mousavi; Panahi, Homayon Ahmad.
Afiliação
  • Soltani A; Department of Chemical Engineering, Yasuj Branch, Islamic Azad University, Yasuj, Iran.
  • Faramarzi M; Department of Chemical Engineering, Yasuj Branch, Islamic Azad University, Yasuj, Iran; Department of Chemical Engineering, Gachsaran Branch, Islamic Azad University, Gachsaran, Iran. Electronic address: Mehdi.Faramarzi@iau.ac.ir.
  • Farjadian F; Pharmaceutical Sciences Research Center, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Parsa SAM; Department of Chemical Engineering, Yasuj Branch, Islamic Azad University, Yasuj, Iran.
  • Panahi HA; Department of Chemistry, Central Tehran Branch, Islamic Azad University, Tehran, Iran.
Int J Biol Macromol ; 221: 508-522, 2022 Nov 30.
Article em En | MEDLINE | ID: mdl-36089082
ABSTRACT
The present study synthesized a new kind of pH-responsive active targeting glycodendrimer (ATGD) for doxorubicin delivery to cancerous cells. First, the glycodendrimer was synthesized based on the cultivation of chitosan dendrons on amine-functionalized, silica-grafted cellulose nanocrystals. Afterward, glycodendrimer was conjugated with folic acid to provide a folate receptor-targeting agent. The response surface method was employed to obtain the optimum conditions for the preparation of doxorubicin-loaded ATGD. The effect of doxorubicin/ATGD ratio, temperature, and pH on doxorubicin loading capacity was evaluated, and high loading capacity was achieved under optimized conditions. After determining doxorubicin release pattern at acidic and physiological pH, ATGD cytotoxicity was surveyed by MTT assay. Based on the results, the loading behavior of doxorubicin onto ATGD was in good agreement with monolayer-physisorption, and drug release was Fickian diffusion-controlled. ATGD could release the doxorubicin much more at acidic pH than physiological pH, corresponding to pH-responsive release behavior. Results of MTT assay confirmed the cytotoxicity of doxorubicin-loaded ATGD in cancer cells, while ATGD (without drug) was biocompatible with no tangible toxicity. These results suggested that ATGD has the potential for the treatment of cancer.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quitosana / Nanopartículas Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quitosana / Nanopartículas Idioma: En Ano de publicação: 2022 Tipo de documento: Article